#2 would have been largely in scope, I think. GiveWell’s analyses usually include an adjustment for estimated crowding out of other public health expenditures.
#1 is more a cause-prioritization argument in my book. The basic contours of that argument are fairly clear and well-known; the added value would be in identifying a specific program that can be implemented within the money available to EA orgs for global health/development and running a convincing cost-benefit analysis on it. That’s a much harder thing to model than GiveWell-type interventions and would need a lot more incentive/resources than $20K.
#2 would have been largely in scope, I think. GiveWell’s analyses usually include an adjustment for estimated crowding out of other public health expenditures.
#1 is more a cause-prioritization argument in my book. The basic contours of that argument are fairly clear and well-known; the added value would be in identifying a specific program that can be implemented within the money available to EA orgs for global health/development and running a convincing cost-benefit analysis on it. That’s a much harder thing to model than GiveWell-type interventions and would need a lot more incentive/resources than $20K.